Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2005-12-02

Original market date: See footnote 1

2005-12-02

Product name:

AVONEX

Description:

PREFILLED SYRINGE, PREFILLED AUTOINJECTOR

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02269201

Product Monograph/Veterinary Labelling:

Date: 2020-05-26 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

BIOGEN CANADA INC
3250 Bloor Street West, East Tower, Suite 1200
Toronto
Ontario
Canada  M8X 2X9

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Schedule D,  Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

92:20.00   Immunomodulatory Agents

Anatomical Therapeutic Chemical (ATC): See footnote 4

L03AB07  INTERFERON BETA-1A

Active ingredient group (AIG) number:See footnote 5

0131806004

List of active ingredient(s)
Active ingredient(s) Strength
INTERFERON BETA-1A 30 MCG / 0.5 ML

Application information

Related information

Contact us

Version 3.9.0
Date modified: